Home | Volume 12

A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics

Dr. Kenneth Blum et. al.

Download as PDF : 34._Blum_et_al,_371-382.pdf : 1144987 bytes


Previous Article: The ATP-driven protein translocation-motor of mitochondria
Next Article: Severe phenotype of Morquio A disease in a child with S287L N-acetylgalactosamine-6-sulfate sulfatase mutation
The Publication:
A short term pilot open label study to evaluate efficacy and safety of LG839, a customized DNA directed nutraceutical in obesity: Exploring Nutrigenomics
is not formatted in HTML just yet, but will be available very soon!
Please view as a PDF: 34._Blum_et_al,_371-382.pdf in the meantime.